American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
-
Am J Health Syst Pharm · Jun 2008
ReviewTreatment of alcohol withdrawal syndrome with carbamazepine, gabapentin, and nitrous oxide.
To evaluate the potential use of carbamazepine, gabapentin, and nitrous oxide as alternatives to symptom-triggered benzodiazepine administration for the treatment of alcohol withdrawal syndrome (AWS), a literature review was conducted. ⋯ Because of the limitations in evidence accrued so far, the routine use of carbamazepine and gabapentin for the treatment of AWS cannot be recommended, and nitrous oxide should be avoided for this indication.
-
Am J Health Syst Pharm · Jun 2008
Case ReportsComplete atrioventricular block associated with rivastigmine therapy.
A case of complete atrioventricular block associated with rivastigmine use is presented. ⋯ A 67-year-old woman developed complete atrioventricular block after receiving rivastigmine for the treatment of Alzheimer's disease.
-
The diagnostic criteria and treatment of insomnia are reviewed. ⋯ Many treatment options are available for patients with insomnia. Behavioral therapies should be initiated as first-line treatment in most patients. For patients who require the addition of pharmacologic therapy, the drugs with the most evidence for benefit include benzodiazepines, benzodiazepine-receptor agonists, melatonin-receptor agonists, and antidepressants. Selection of a specific agent must take into account numerous patient-specific factors.
-
A case of cefazolin-induced hypoprothrombinemia in a patient with renal failure is reported. ⋯ A patient with a postsurgery wound infection and acute renal failure developed hypoprothrombinemia after receiving cefazolin for seven days.